185 related articles for article (PubMed ID: 23274378)
1. Correlating pathology with the clinical symptoms of methotrexate-induced leukoencephalopathy in a child with relapsed T-cell acute lymphoblastic leukemia.
Summers RJ; Abramowsky CR; Cooper TM
J Pediatr Hematol Oncol; 2014 Jan; 36(1):e19-22. PubMed ID: 23274378
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-induced acute toxic leukoencephalopathy.
Salkade PR; Lim TA
J Cancer Res Ther; 2012; 8(2):292-6. PubMed ID: 22842379
[TBL] [Abstract][Full Text] [Related]
4. [Picture in clinical hematology no. 69--Case of asymptomatic limbic leukoencephalopathy due to methotrexate therapy].
Kida J; Uemura M; Araya T; Matsumoto K; Imataki O; Takahashi T; Kimura N
Rinsho Ketsueki; 2014 Jan; 55(1):1. PubMed ID: 24492028
[No Abstract] [Full Text] [Related]
5. Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies.
Tsujimoto S; Yanagimachi M; Tanoshima R; Urayama KY; Tanaka F; Aida N; Goto H; Ito S
Pediatr Blood Cancer; 2016 Nov; 63(11):1983-9. PubMed ID: 27399166
[TBL] [Abstract][Full Text] [Related]
6. Acute methotrexate neurotoxicity with choreiform movements and focal neurological deficits: a case report.
Bota DA; Dafer RM
South Med J; 2009 Oct; 102(10):1071-4. PubMed ID: 19738521
[TBL] [Abstract][Full Text] [Related]
7. Repeated Episodes of Leukoencephalopathy after High-dose Methotrexate in a Child with Acute Lymphoblastic Leukemia.
Tsao TF; Chao YH
Indian Pediatr; 2017 Feb; 54(2):159. PubMed ID: 28285295
[No Abstract] [Full Text] [Related]
8. MRI findings in methotrexate-induced acute toxic leukoencephalopathy.
Jakkani RK; Krishna Reddy GV; Anasuri S; Suvarna H; Kumar MS; Satyanarayan S
Neurol India; 2017; 65(6):1439-1440. PubMed ID: 29133739
[No Abstract] [Full Text] [Related]
9. [Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].
Garcia-Puig M; Fons-Estupina MC; Rives-Sola S; Berrueco-Moreno R; Cruz-Martinez O; Campistol J
Rev Neurol; 2012 Jun; 54(12):712-8. PubMed ID: 22673947
[TBL] [Abstract][Full Text] [Related]
10. Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia.
Hartz B; Löbel U; Hagel C; Escherich G
Am J Hematol; 2013 Dec; 88(12):1096-7. PubMed ID: 23873785
[No Abstract] [Full Text] [Related]
11. Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke.
Agarwal A; Vijay K; Thamburaj K; Ouyang T
Emerg Radiol; 2011 Aug; 18(4):345-7. PubMed ID: 21243392
[TBL] [Abstract][Full Text] [Related]
12. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
[TBL] [Abstract][Full Text] [Related]
13. A unique radiological case of intrathecal methotrexate-induced toxic leukoencephalopathy.
Yang J; Kim GS; Park HM
J Neurol Sci; 2015; 353(1-2):169-71. PubMed ID: 25912173
[No Abstract] [Full Text] [Related]
14. Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group.
Duffner PK; Armstrong FD; Chen L; Helton KJ; Brecher ML; Bell B; Chauvenet AR
J Pediatr Hematol Oncol; 2014 Jan; 36(1):8-15. PubMed ID: 24345882
[TBL] [Abstract][Full Text] [Related]
15. Subacute methotrexate-related leukoencephalopathy with stroke-like presentation.
Iwatani K; Fujii N; Deguchi S; Tanimoto M
Int J Hematol; 2012 Dec; 96(6):683-4. PubMed ID: 23114968
[No Abstract] [Full Text] [Related]
16. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
[TBL] [Abstract][Full Text] [Related]
18. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate leukoencephalopathy mimics acute progressive stroke.
Tanaka R; Sasaki-Ikesawa K; Shimura H; Nishioka K; Hattori N; Tanaka S
J Neurol; 2011 Nov; 258(11):2083-5. PubMed ID: 21512738
[No Abstract] [Full Text] [Related]
20. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy.
Yamamoto A; Miki Y; Adachi S; Kanagaki M; Fushimi Y; Okada T; Kobayashi M; Hiramatsu H; Umeda K; Nakahata T; van Buchem MA; Togashi K
Eur J Radiol; 2006 Mar; 57(3):423-7. PubMed ID: 16314063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]